Skip to main content
SRPT logo

SRPT · Sarepta Therapeutics, Inc. · Analyst Estimates

Track SRPT — free
$18.22 -0.42 (-2.25%) At close · Sep 30
Market Cap
$1.97B
Shares
105.63M
Volume · Sep 30 2M Avg daily vol (3M) 3.07M

Analyst Estimates

Compare analyst forecasts for Sarepta Therapeutics, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-10-01 02:29 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
2.87502
4.33715
6.0
—
4.4379
4.78556
4.43569
4.8301
— — — —
EPS
analysts
Publication date not stated
— — —
10
— — — —
7
0
4
1
Revenue
USD
Publication date not stated
1796000000
1836481150
1915700000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
20
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
0.53327
2.41104
4.79
—
2.5693
2.44799
2.63223
2.72566
— — — —
EPS
analysts
Publication date not stated
— — —
10
— — — —
5
1
6
0
Revenue
USD
Publication date not stated
909506680
1380648840
1774000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
19
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.06043
0.37234
1.13
—
0.42046
0.48459
0.42046
0.4957
— — — —
EPS
analysts
Publication date not stated
— — —
10
— — — —
5
0
4
1
Revenue
USD
Publication date not stated
332879890
353147350
392200000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
18
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-1.07302
0.11677
1.08
—
0.16705
0.43377
0.16705
0.44377
— — — —
EPS
analysts
Publication date not stated
— — —
10
— — — —
7
0
2
1
Revenue
USD
Publication date not stated
327100000
351921430
391500000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
18
— — — — — — — —
Key facts CIK 873303 CUSIP 803607100 13F (30d) 9 filings 9 filers Visit website Investor relations